These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27886440)

  • 1. The forgotten place of radioembolization for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis.
    Levi Sandri GB; Lai Q; Lucatelli P
    Liver Int; 2017 Mar; 37(3):469-470. PubMed ID: 27886440
    [No Abstract]   [Full Text] [Related]  

  • 2. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
    Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
    Cancer; 2015 Jul; 121(13):2164-74. PubMed ID: 25847227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis.
    Jia Z; Jiang G; Tian F; Zhu C; Qin X
    Saudi J Gastroenterol; 2016; 22(5):353-359. PubMed ID: 27748320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization.
    Lorenzin D; Pravisani R; Leo CA; Bugiantella W; Soardo G; Carnelutti A; Umberto B; Risaliti A
    Cancer Biother Radiopharm; 2016 Mar; 31(2):65-9. PubMed ID: 26986817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with
    Garin E; Rolland Y; Pracht M; Le Sourd S; Laffont S; Mesbah H; Haumont LA; Lenoir L; Rohou T; Brun V; Edeline J
    Liver Int; 2017 Jan; 37(1):101-110. PubMed ID: 27514012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization.
    Xing M; Kokabi N; Camacho JC; Kim HS
    BMC Cancer; 2018 Jan; 18(1):75. PubMed ID: 29329568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
    Kulik LM; Carr BI; Mulcahy MF; Lewandowski RJ; Atassi B; Ryu RK; Sato KT; Benson A; Nemcek AA; Gates VL; Abecassis M; Omary RA; Salem R
    Hepatology; 2008 Jan; 47(1):71-81. PubMed ID: 18027884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis.
    Akinwande O; Kim D; Edwards J; Brown R; Philips P; Scoggins C; Martin RC
    Surg Oncol; 2015 Sep; 24(3):270-5. PubMed ID: 26133576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
    Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.
    Cho YY; Lee M; Kim HC; Chung JW; Kim YH; Gwak GY; Bae SH; Kim do Y; Heo J; Kim YJ
    PLoS One; 2016; 11(5):e0154986. PubMed ID: 27149067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.
    Golfieri R; Mosconi C; Cappelli A; Giampalma E; Galaverni MC; Pettinato C; Renzulli M; Monari F; Angelelli B; Pini P; Terzi E; Ascanio S; Garzillo G; Piscaglia F; Bolondi L; Trevisani F
    Future Oncol; 2015; 11(23):3133-42. PubMed ID: 26467398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstaging of bilobar hepatocellular carcinoma after radioembolization with
    Reguera-Berenguer L; Orcajo-Rincón J; Rotger-Regí A; Matilla-Peña AM; Echenagusia-Boyra M; Pérez-Pascual R; Marí-Hualde A; Alonso-Farto JC
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):329-332. PubMed ID: 28268101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonsurgical management of hepatocellular carcinoma].
    Merle P; Mornex F
    Cancer Radiother; 2010 Oct; 14(6-7):469-73. PubMed ID: 20739209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/CT after yttrium-90 radioembolization: current and future applications.
    Gates VL; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2013 Aug; 24(8):1153-5. PubMed ID: 23885913
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes of radioembolization for unresectable hepatocellular carcinoma in patients with marginal functional hepatic reserve.
    Biederman DM; Posham R; Durrani RJ; Titano JJ; Patel RS; Tabori NE; Nowakowski FS; Fischman AM; Lookstein RA; Kim E
    Clin Imaging; 2018; 47():34-40. PubMed ID: 28834778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplantation After Downstaging of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Using Yttrium-90 Radioembolization: Pipe Dream or Reality?
    Mehta N; Yao FY
    Liver Transpl; 2021 Dec; 27(12):1706-1708. PubMed ID: 34529890
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to: "Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion".
    Sposito C; Spreafico C; Mazzaferro V
    J Hepatol; 2018 Jul; 69(1):260-261. PubMed ID: 29705239
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels.
    Ahmadzadehfar H; Pieper CC; Ezziddin S; Biersack HJ; Meyer C
    Clin Nucl Med; 2014 Mar; 39(3):305-7. PubMed ID: 24458185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90.
    Lau WY; Sangro B; Chen PJ; Cheng SQ; Chow P; Lee RC; Leung T; Han KH; Poon RT
    Oncology; 2013; 84(5):311-8. PubMed ID: 23615394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.